Home > Insider Trading > Filing (0001209191-23-004684)

Filing Details

Accession Number:: 0001209191-23-004684
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-01-24 18:33:10
Reporting Period:: 2023-01-23

Accepted Time:: 2023-01-24 18:33:10
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1851194	Ventyx Biosciences Inc.	VTYX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1778739	Richard William White	C/O Ventyx Biosciences, Inc. 662 Encinitas Blvd, Suite 250 Encinitas CA 92024		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2023-01-23	33,353	$6.03	33,353	No	4	M	Direct
Common Stock	Disposition	2023-01-23	5,048	$34.33	28,305	No	4	S	Direct
Common Stock	Disposition	2023-01-23	21,278	$35.01	7,027	No	4	S	Direct
Common Stock	Disposition	2023-01-23	7,027	$35.91	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2023-01-23	33,353	$0.00	33,353	$6.03

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
119,120		2031-08-17	No	4	M	Direct

Footnotes

Shares were sold pursuant to a 10b5-1 trading plan adopted by the reporting person on September 22, 2022.
The sales price reported is the weighted average sale price for 5,048 shares sold. These shares were sold in multiple transactions at prices ranging from $33.70 to $34.695 by the reporting person. Full information regarding the number of shares sold at each separate price will be supplied upon request by Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer.
The sales price reported is the weighted average sale price for 21,278 shares sold. These shares were sold in multiple transactions at prices ranging from $34.705 to $35.7029 by the reporting person. Full information regarding the number of shares sold at each separate price will be supplied upon request by Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer.
The sales price reported is the weighted average sale price for 7,027 shares sold. These shares were sold in multiple transactions at prices ranging from $35.7054 to $36.48 by the reporting person. Full information regarding the number of shares sold at each separate price will be supplied upon request by Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer.
Option granted under pursuant to the Issuer's 2019 Equity Incentive Plan, as amended (the "2019 Plan"). Subject to the Reporting Person continuing to be a Service Provider (as defined 2019 Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean May 22, 2021.